A 1996 Michigan law, exclusive to the state, restricts consumers from suing pharmaceutical companies unless they can prove the company deceived the Food and Drug Administration.
And even that provision, opponents of the law say, has been struck down before in federal courts. But supporters of the drug immunity law say it prevents frivolous lawsuits and is based on what they call the "gold-standard" of drug approval processes.
Representative Dianne Byrum is waiting on legislation introduced earlier this year that would repeal the 1996 law. Chuck Hadden of the Michigan Manufacturers Association says it would be a big mistake for the state to support the repeal and that it would result in many frivolous lawsuits.